Call to prioritise nanomedicine:
This article was originally published in Clinica
Executive Summary
Nanomedicine is a valuable new technology for diagnostics and should have a higher profile in medicine, according to influential medical journal The Lancet. The statement in its August 30 2003 issue follows a review of nanoscience by the US National Institutes of Health (NIH), which highlighted disease diagnosis and treatment as key areas in which the discipline could help mankind. According to NIH, nanostructures (defined as between 1-100nm in size) offer "novel means for body or organ imaging. Nanotweezers and surgical tools only a few nanometers thick are already in development. Nanoprobes may be able to add diagnostic specificity to biopsy studies."
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.